Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- TD Cowen analyst Ritu Baral initiated coverage on Akero Therapeutics, Inc. AKRO with a Buy rating and announced a price target of $76. Akero Therapeutics shares closed at $48.37 on Friday. See how other analysts view this stock.
- JMP Securities analyst Trevor Walsh initiated coverage on AeroVironment, Inc. AVAV with a Market Outperform rating and announced a price target of $325. AeroVironment shares closed at $260.07 on Friday. See how other analysts view this stock.
- Canaccord Genuity analyst Whitney Ijem initiated coverage on Wave Life Sciences Ltd. WVE with a Buy rating and announced a price target of $19. WAVE Life Sciences shares closed at $8.63 on Friday. See how other analysts view this stock.
- LifeSci Capital analyst Sam Slutsky initiated coverage on Palvella Therapeutics, Inc. PVLA with an Outperform rating and announced a price target of $90. Palvella Therapeutics shares closed at $36.55 on Friday. See how other analysts view this stock.
- UBS analyst Paul Gong initiated coverage on WeRide Inc. WRD with a Buy rating and announced a price target of $12. WeRide shares closed at $8.65 on Friday. See how other analysts view this stock.
Considering buying AVAV stock? Here’s what analysts think:
Trending Investment Opportunities
Advertisement
Read This Next:
Photo via Shutterstock
Loading...
Loading...
AIVApartment Investment & Management Co
$8.770.98%
Edge Rankings
Momentum
32.54
Growth
4.25
Quality
N/A
Value
46.56
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|